Skip to content

To determine the efficacy of sunscreens in the treatment of melasma as assessed(measured) by Melasma Quality of life

To determine the efficacy of sunscreens in the treatment of melasma as assessed by MASI and Hindi Melasma Quality Of Life Index

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/05/006965
Enrollment
100
Registered
2016-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Melasma

Interventions

Intervention1: Broad Band Sunscreen of SPF 19: The Melama Quality of Life will be compared both before and after using the sunscreen Intervention2: Garnier White complete stearate gel: TOPICAL, ONCE F

Sponsors

Indian Association of Dermatologists Venereologists and LeprologistsIADVL
Lead Sponsor
Loreal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with clinical diagnosis of Melasma. 2. Naïve patients, not on any therapy.

Exclusion criteria

Exclusion criteria: 1. Age less than 20 years. 2. History of intake of Oral contraceptives 3. History of photosensitivity 4. Pregnant/nursing patient 5. Patient taking photosensitizing medications 6. Family history of melasma 7. Thyroid abnormality

Design outcomes

Primary

MeasureTime frame
Sunlight has been proposed as one of the most important triggering event in the etiopathogenesis of melasma. However there are very few studies that evaluate its role in the treatment of melasma. Also, the impact of melasma and its treatment on the quality of life has assessed by the Hindi Melasma Quality Of Life Index has not been assessed before in the Indian setup.Timepoint: 12 weeks

Secondary

MeasureTime frame
To observe tolerability to sunscreen of the patients over 12 weeksTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Rashmi Sarkar

Maulana Azad Medical College and Lok Nayak Hospital

rashmisarkar@gmail.com9818244340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026